pentakis(carbon dioxide);3,4-dimethylaniline;N-(3,4-dimethylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;N-(3-methoxy-4-methylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine;N-[3-[2-[2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]ethyl]-4-methylphenyl]-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;3-(4-methylimidazol-1-yl)-N-[4-methyl-3-[2-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)ethyl]phenyl]-5-(trifluoromethyl)benzamide;2-methyl-1H-pyrrolo[2,3-b]pyridin-5-amine;4-methyl-1-[3-(trifluoromethyl)phenyl]imidazole

C140H130F15N25O17 — CID 161157755

IUPACpentakis(carbon dioxide);3,4-dimethylaniline;N-(3,4-dimethylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;N-(3-methoxy-4-methylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine;N-[3-[2-[2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]ethyl]-4-methylphenyl]-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;3-(4-methylimidazol-1-yl)-N-[4-methyl-3-[2-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)ethyl]phenyl]-5-(trifluoromethyl)benzamide;2-methyl-1H-pyrrolo[2,3-b]pyridin-5-amine;4-methyl-1-[3-(trifluoromethyl)phenyl]imidazole
SMILESCOCc1cc2cc(CCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1.COCc1cc2cc(N)cnc2[nH]1.COc1cc(NC(=O)c2cc(-n3cnc(C)c3)cc(C(F)(F)F)c2)ccc1C.Cc1cc2cc(N)cnc2[nH]1.Cc1ccc(N)cc1C.Cc1cn(-c2cc(C(=O)Nc3ccc(C)c(C)c3)cc(C(F)(F)F)c2)cn1.Cc1cn(-c2cc(C(=O)Nc3ccc(C)c(CCc4cnc5[nH]c(C)cc5c4)c3)cc(C(F)(F)F)c2)cn1.Cc1cn(-c2cccc(C(F)(F)F)c2)cn1.O=C=O.O=C=O.O=C=O.O=C=O.O=C=O
InChIInChI=1S/C30H28F3N5O2.C29H26F3N5O.C20H18F3N3O2.C20H18F3N3O.C11H9F3N2.C9H11N3O.C8H9N3.C8H11N.5CO2/c1-18-4-7-25(10-21(18)6-5-20-8-22-11-26(16-40-3)36-28(22)34-14-20)37-29(39)23-9-24(30(31,32)33)13-27(12-23)38-15-19(2)35-17-38;1-17-4-7-25(11-21(17)6-5-20-9-22-8-18(2)35-27(22)33-14-20)36-28(38)23-10-24(29(30,31)32)13-26(12-23)37-15-19(3)34-16-37;1-12-4-5-16(9-18(12)28-3)25-19(27)14-6-15(20(21,22)23)8-17(7-14)26-10-13(2)24-11-26;1-12-4-5-17(6-13(12)2)25-19(27)15-7-16(20(21,22)23)9-18(8-15)26-10-14(3)24-11-26;1-8-6-16(7-15-8)10-4-2-3-9(5-10)11(12,13)14;1-13-5-8-3-6-2-7(10)4-11-9(6)12-8;1-5-2-6-3-7(9)4-10-8(6)11-5;1-6-3-4-8(9)5-7(6)2;5*2-1-3/h4,7-15,17H,5-6,16H2,1-3H3,(H,34,36)(H,37,39);4,7-16H,5-6H2,1-3H3,(H,33,35)(H,36,38);4-11H,1-3H3,(H,25,27);4-11H,1-3H3,(H,25,27);2-7H,1H3;2-4H,5,10H2,1H3,(H,11,12);2-4H,9H2,1H3,(H,10,11);3-5H,9H2,1-2H3;;;;;
InChIKeyUPNCLHSAZJEGSG-UHFFFAOYSA-N
MW2719.71 g/mol
LogP28.05
Rot. Bonds24

About pentakis(carbon dioxide);3,4-dimethylaniline;N-(3,4-dimethylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;N-(3-methoxy-4-methylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine;N-[3-[2-[2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]ethyl]-4-methylphenyl]-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;3-(4-methylimidazol-1-yl)-N-[4-methyl-3-[2-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)ethyl]phenyl]-5-(trifluoromethyl)benzamide;2-methyl-1H-pyrrolo[2,3-b]pyridin-5-amine;4-methyl-1-[3-(trifluoromethyl)phenyl]imidazole

pentakis(carbon dioxide);3,4-dimethylaniline;N-(3,4-dimethylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;N-(3-methoxy-4-methylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine;N-[3-[2-[2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]ethyl]-4-methylphenyl]-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;3-(4-methylimidazol-1-yl)-N-[4-methyl-3-[2-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)ethyl]phenyl]-5-(trifluoromethyl)benzamide;2-methyl-1H-pyrrolo[2,3-b]pyridin-5-amine;4-methyl-1-[3-(trifluoromethyl)phenyl]imidazole (PubChem CID 161157755) has the molecular formula C140H130F15N25O17 and a molecular weight of 2719.71 g/mol. Its IUPAC name is pentakis(carbon dioxide);3,4-dimethylaniline;N-(3,4-dimethylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;N-(3-methoxy-4-methylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine;N-[3-[2-[2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]ethyl]-4-methylphenyl]-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;3-(4-methylimidazol-1-yl)-N-[4-methyl-3-[2-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)ethyl]phenyl]-5-(trifluoromethyl)benzamide;2-methyl-1H-pyrrolo[2,3-b]pyridin-5-amine;4-methyl-1-[3-(trifluoromethyl)phenyl]imidazole.

Molecular Properties

Compound Namepentakis(carbon dioxide);3,4-dimethylaniline;N-(3,4-dimethylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;N-(3-methoxy-4-methylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine;N-[3-[2-[2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]ethyl]-4-methylphenyl]-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;3-(4-methylimidazol-1-yl)-N-[4-methyl-3-[2-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)ethyl]phenyl]-5-(trifluoromethyl)benzamide;2-methyl-1H-pyrrolo[2,3-b]pyridin-5-amine;4-methyl-1-[3-(trifluoromethyl)phenyl]imidazole
PubChem CID161157755
Molecular FormulaC140H130F15N25O17
Molecular Weight2719.71 g/mol
Exact Mass2717.98
IUPAC Namepentakis(carbon dioxide);3,4-dimethylaniline;N-(3,4-dimethylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;N-(3-methoxy-4-methylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine;N-[3-[2-[2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]ethyl]-4-methylphenyl]-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;3-(4-methylimidazol-1-yl)-N-[4-methyl-3-[2-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)ethyl]phenyl]-5-(trifluoromethyl)benzamide;2-methyl-1H-pyrrolo[2,3-b]pyridin-5-amine;4-methyl-1-[3-(trifluoromethyl)phenyl]imidazole
SMILESCOCc1cc2cc(CCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1.COCc1cc2cc(N)cnc2[nH]1.COc1cc(NC(=O)c2cc(-n3cnc(C)c3)cc(C(F)(F)F)c2)ccc1C.Cc1cc2cc(N)cnc2[nH]1.Cc1ccc(N)cc1C.Cc1cn(-c2cc(C(=O)Nc3ccc(C)c(C)c3)cc(C(F)(F)F)c2)cn1.Cc1cn(-c2cc(C(=O)Nc3ccc(C)c(CCc4cnc5[nH]c(C)cc5c4)c3)cc(C(F)(F)F)c2)cn1.Cc1cn(-c2cccc(C(F)(F)F)c2)cn1.O=C=O.O=C=O.O=C=O.O=C=O.O=C=O
InChIInChI=1S/C30H28F3N5O2.C29H26F3N5O.C20H18F3N3O2.C20H18F3N3O.C11H9F3N2.C9H11N3O.C8H9N3.C8H11N.5CO2/c1-18-4-7-25(10-21(18)6-5-20-8-22-11-26(16-40-3)36-28(22)34-14-20)37-29(39)23-9-24(30(31,32)33)13-27(12-23)38-15-19(2)35-17-38;1-17-4-7-25(11-21(17)6-5-20-9-22-8-18(2)35-27(22)33-14-20)36-28(38)23-10-24(29(30,31)32)13-26(12-23)37-15-19(3)34-16-37;1-12-4-5-16(9-18(12)28-3)25-19(27)14-6-15(20(21,22)23)8-17(7-14)26-10-13(2)24-11-26;1-12-4-5-17(6-13(12)2)25-19(27)15-7-16(20(21,22)23)9-18(8-15)26-10-14(3)24-11-26;1-8-6-16(7-15-8)10-4-2-3-9(5-10)11(12,13)14;1-13-5-8-3-6-2-7(10)4-11-9(6)12-8;1-5-2-6-3-7(9)4-10-8(6)11-5;1-6-3-4-8(9)5-7(6)2;5*2-1-3/h4,7-15,17H,5-6,16H2,1-3H3,(H,34,36)(H,37,39);4,7-16H,5-6H2,1-3H3,(H,33,35)(H,36,38);4-11H,1-3H3,(H,25,27);4-11H,1-3H3,(H,25,27);2-7H,1H3;2-4H,5,10H2,1H3,(H,11,12);2-4H,9H2,1H3,(H,10,11);3-5H,9H2,1-2H3;;;;;
InChIKeyUPNCLHSAZJEGSG-UHFFFAOYSA-N
XLogP28.05
TPSA596.67 Ų
H-Bond Donors11
H-Bond Acceptors34
Rotatable Bonds24
Heavy Atoms197
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002719.71
LogP ≤ 528.05
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1034

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aniline', 'substructure': 'N/A'}

Analyze pentakis(carbon dioxide);3,4-dimethylaniline;N-(3,4-dimethylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;N-(3-methoxy-4-methylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine;N-[3-[2-[2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]ethyl]-4-methylphenyl]-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;3-(4-methylimidazol-1-yl)-N-[4-methyl-3-[2-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)ethyl]phenyl]-5-(trifluoromethyl)benzamide;2-methyl-1H-pyrrolo[2,3-b]pyridin-5-amine;4-methyl-1-[3-(trifluoromethyl)phenyl]imidazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of pentakis(carbon dioxide);3,4-dimethylaniline;N-(3,4-dimethylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;N-(3-methoxy-4-methylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine;N-[3-[2-[2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]ethyl]-4-methylphenyl]-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;3-(4-methylimidazol-1-yl)-N-[4-methyl-3-[2-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)ethyl]phenyl]-5-(trifluoromethyl)benzamide;2-methyl-1H-pyrrolo[2,3-b]pyridin-5-amine;4-methyl-1-[3-(trifluoromethyl)phenyl]imidazole?
The IUPAC name of pentakis(carbon dioxide);3,4-dimethylaniline;N-(3,4-dimethylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;N-(3-methoxy-4-methylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine;N-[3-[2-[2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]ethyl]-4-methylphenyl]-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;3-(4-methylimidazol-1-yl)-N-[4-methyl-3-[2-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)ethyl]phenyl]-5-(trifluoromethyl)benzamide;2-methyl-1H-pyrrolo[2,3-b]pyridin-5-amine;4-methyl-1-[3-(trifluoromethyl)phenyl]imidazole (CID 161157755) is pentakis(carbon dioxide);3,4-dimethylaniline;N-(3,4-dimethylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;N-(3-methoxy-4-methylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine;N-[3-[2-[2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]ethyl]-4-methylphenyl]-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;3-(4-methylimidazol-1-yl)-N-[4-methyl-3-[2-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)ethyl]phenyl]-5-(trifluoromethyl)benzamide;2-methyl-1H-pyrrolo[2,3-b]pyridin-5-amine;4-methyl-1-[3-(trifluoromethyl)phenyl]imidazole.
What is the SMILES notation for pentakis(carbon dioxide);3,4-dimethylaniline;N-(3,4-dimethylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;N-(3-methoxy-4-methylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine;N-[3-[2-[2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]ethyl]-4-methylphenyl]-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;3-(4-methylimidazol-1-yl)-N-[4-methyl-3-[2-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)ethyl]phenyl]-5-(trifluoromethyl)benzamide;2-methyl-1H-pyrrolo[2,3-b]pyridin-5-amine;4-methyl-1-[3-(trifluoromethyl)phenyl]imidazole?
The canonical SMILES for pentakis(carbon dioxide);3,4-dimethylaniline;N-(3,4-dimethylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;N-(3-methoxy-4-methylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine;N-[3-[2-[2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]ethyl]-4-methylphenyl]-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;3-(4-methylimidazol-1-yl)-N-[4-methyl-3-[2-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)ethyl]phenyl]-5-(trifluoromethyl)benzamide;2-methyl-1H-pyrrolo[2,3-b]pyridin-5-amine;4-methyl-1-[3-(trifluoromethyl)phenyl]imidazole is COCc1cc2cc(CCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1.COCc1cc2cc(N)cnc2[nH]1.COc1cc(NC(=O)c2cc(-n3cnc(C)c3)cc(C(F)(F)F)c2)ccc1C.Cc1cc2cc(N)cnc2[nH]1.Cc1ccc(N)cc1C.Cc1cn(-c2cc(C(=O)Nc3ccc(C)c(C)c3)cc(C(F)(F)F)c2)cn1.Cc1cn(-c2cc(C(=O)Nc3ccc(C)c(CCc4cnc5[nH]c(C)cc5c4)c3)cc(C(F)(F)F)c2)cn1.Cc1cn(-c2cccc(C(F)(F)F)c2)cn1.O=C=O.O=C=O.O=C=O.O=C=O.O=C=O.
What is the InChIKey of pentakis(carbon dioxide);3,4-dimethylaniline;N-(3,4-dimethylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;N-(3-methoxy-4-methylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine;N-[3-[2-[2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]ethyl]-4-methylphenyl]-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;3-(4-methylimidazol-1-yl)-N-[4-methyl-3-[2-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)ethyl]phenyl]-5-(trifluoromethyl)benzamide;2-methyl-1H-pyrrolo[2,3-b]pyridin-5-amine;4-methyl-1-[3-(trifluoromethyl)phenyl]imidazole?
The InChIKey is UPNCLHSAZJEGSG-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H28F3N5O2.C29H26F3N5O.C20H18F3N3O2.C20H18F3N3O.C11H9F3N2.C9H11N3O.C8H9N3.C8H11N.5CO2/c1-18-4-7-25(10-21(18)6-5-20-8-22-11-26(16-40-3)36-28(22)34-14-20)37-29(39)23-9-24(30(31,32)33)13-27(12-23)38-15-19(2)35-17-38;1-17-4-7-25(11-21(17)6-5-20-9-22-8-18(2)35-27(22)33-14-20)36-28(38)23-10-24(29(30,31)32)13-26(12-23)37-15-19(3)34-16-37;1-12-4-5-16(9-18(12)28-3)25-19(27)14-6-15(20(21,22)23)8-17(7-14)26-10-13(2)24-11-26;1-12-4-5-17(6-13(12)2)25-19(27)15-7-16(20(21,22)23)9-18(8-15)26-10-14(3)24-11-26;1-8-6-16(7-15-8)10-4-2-3-9(5-10)11(12,13)14;1-13-5-8-3-6-2-7(10)4-11-9(6)12-8;1-5-2-6-3-7(9)4-10-8(6)11-5;1-6-3-4-8(9)5-7(6)2;5*2-1-3/h4,7-15,17H,5-6,16H2,1-3H3,(H,34,36)(H,37,39);4,7-16H,5-6H2,1-3H3,(H,33,35)(H,36,38);4-11H,1-3H3,(H,25,27);4-11H,1-3H3,(H,25,27);2-7H,1H3;2-4H,5,10H2,1H3,(H,11,12);2-4H,9H2,1H3,(H,10,11);3-5H,9H2,1-2H3;;;;;.
What are the key properties of pentakis(carbon dioxide);3,4-dimethylaniline;N-(3,4-dimethylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;N-(3-methoxy-4-methylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine;N-[3-[2-[2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]ethyl]-4-methylphenyl]-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;3-(4-methylimidazol-1-yl)-N-[4-methyl-3-[2-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)ethyl]phenyl]-5-(trifluoromethyl)benzamide;2-methyl-1H-pyrrolo[2,3-b]pyridin-5-amine;4-methyl-1-[3-(trifluoromethyl)phenyl]imidazole?
pentakis(carbon dioxide);3,4-dimethylaniline;N-(3,4-dimethylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;N-(3-methoxy-4-methylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine;N-[3-[2-[2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]ethyl]-4-methylphenyl]-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;3-(4-methylimidazol-1-yl)-N-[4-methyl-3-[2-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)ethyl]phenyl]-5-(trifluoromethyl)benzamide;2-methyl-1H-pyrrolo[2,3-b]pyridin-5-amine;4-methyl-1-[3-(trifluoromethyl)phenyl]imidazole has a molecular weight of 2719.71 g/mol, XLogP of 28.05, 24 rotatable bonds, 11 hydrogen bond donors, and 34 hydrogen bond acceptors.
Where does this data come from?
All data for pentakis(carbon dioxide);3,4-dimethylaniline;N-(3,4-dimethylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;N-(3-methoxy-4-methylphenyl)-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine;N-[3-[2-[2-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]ethyl]-4-methylphenyl]-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide;3-(4-methylimidazol-1-yl)-N-[4-methyl-3-[2-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)ethyl]phenyl]-5-(trifluoromethyl)benzamide;2-methyl-1H-pyrrolo[2,3-b]pyridin-5-amine;4-methyl-1-[3-(trifluoromethyl)phenyl]imidazole is sourced from PubChem (CID 161157755), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).